HopeStage
Back to all studies
CompletedNCT00158158

Smoking reduction to support quitting among adolescents

About this titleRead the official source — NCT00158158
Placebo comparisonAges 13–19United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 13 years to 19 years.

Listed locations
MinneapolisSee all locations and recruitment
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateSeptember 2005
Recruitment status
Completed
Enrollment listed in the registry
200
Sponsor
National Institute on Drug Abuse (NIDA)
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug, Other
Study phase
Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States
Age range
From 13 Years to 19 Years
Official registry ID
NCT00158158
Official title
Show the full official title

Interventions for Tobacco Dependent Adolescents

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Minneapolis

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Institute on Drug Abuse (NIDA), a research institute.

Did this study involve medication?

Yes. The study involved medication, including Usual Care.

Who was this study for?

Listed age limits: 13 years to 19 years.

Want to explore more studies?

Explore studies